1. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS‐650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. Issue 9 (28th January 2015) Authors: Mosure, Kathleen W.; Knipe, Jay O.; Browning, Marc; Arora, Vinod; Shu, Yue‐Zhong; Phillip, Thomas; Mcphee, Fiona; Scola, Paul; Balakrishnan, Anand; Soars, Matthew G.; Santone, Kenneth; Sinz, Michael; Donovan, Maureen D.; Langguth, Peter; Polli, James E.; Tamai, Ikumi; Vig, Balvinder; Yu, Lawrence X. Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 9(2015:Sep.) Page Start: 2813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preclinical Pharmacokinetics and In Vitro Metabolism of BMS‐605339: A Novel HCV NS3 Protease Inhibitor. Issue 6 (3rd April 2014) Authors: Jenkins, Susan; Scola, Paul; McPhee, Fiona; Knipe, Jay; Gesenberg, Christoph; Sinz, Michael; Arora, Vinod; Pilcher, Gary; Santone, Kenneth Journal: Journal of pharmaceutical sciences Issue: Volume 103:Issue 6(2014:Jun.) Page Start: 1891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗